Skip to Content

Nobivac Feline 3-HCP

This page contains information on Nobivac Feline 3-HCP for veterinary use.
The information provided typically includes the following:
  • Nobivac Feline 3-HCP Indications
  • Warnings and cautions for Nobivac Feline 3-HCP
  • Direction and dosage information for Nobivac Feline 3-HCP

Nobivac Feline 3-HCP

This treatment applies to the following species:
Company: Intervet/Merck Animal Health

FELINE RHINOTRACHEITIS-CALICI-PANLEUKOPENIA VACCINE

Modified Live Virus

FOR ANIMAL USE ONLY

IN THE ABSENCE OF A VETERINARIAN-CLIENT-PATIENT RELATIONSHIP, FEDERAL REGULATIONS PROHIBIT THE RELABELING, REPACKAGING, RESALE OR REDISTRIBUTION OF THE INDIVIDUAL CONTENTS OF THIS PACKAGE.

THIMEROSAL FREE

Nobivac Feline 3-HCP Indications

This product has been shown to be effective for vaccination of healthy cats 8 weeks of age or older against feline rhinotracheitis, calici and panleukopenia viruses. Duration of Immunity is at least 3 years. To review efficacy and safety data, go to productdata.aphis.usda.gov.

Dosage and Administration

Transfer contents of the sterile diluent vial to the Nobivac® Feline 3-HCP vial aseptically. Mix gently until dissolved. Two doses are required for primary immunization.

Initial vaccination: Inject 1 dose (1 mL) subcutaneously 8 weeks of age or older.

Second vaccination: Inject 1 dose (1 mL) subcutaneously 3 to 4 weeks following the initial vaccination.

The presence of maternal antibodies is known to interfere with the development of active immunity in cats and additional boosters will be required in most young animals. For more information on revaccination frequency, in general or in the face of maternal antibody, consult your veterinarian or the manufacturer.

Precautions

● Store at 2° - 8°C (35°-46°F).

● Do not freeze.

● Use new, non-chemically sterilized needles and syringes.

● Do not mix with other products, except as specified on the label.

● Inactivate unused contents before disposal.

● In case of human exposure, contact a physician.

Warnings

● Contains gentamicin as a preservative.

● Some reports suggest that in cats, the administration of certain veterinary biologicals may induce the development of injection-site fibrosarcomas.

● Do not vaccinate pregnant cats.

● The use of a biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions. Antidote: Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.

Intervet Inc. d/b/a Merck Animal Health

Omaha, NE 68103 USA

VLN 165A/PCN 16D1.22

1 800 224-5318 (USA)

1 866 683-7838 (CAN)

For patent information:

http://www.merck.com/product/patent/home.html

 

Code

 

25x1 DOSE

031664

353796-03

CPN: 1047461.4

MERCK ANIMAL HEALTH
Intervet Inc.

2 GIRALDA FARMS, MADISON, NJ, 07940
Customer Service:   800-521-5767
Order Desk:   800-648-2118
Technical Service (Companion Animal):   800-224-5318
Technical Service (Livestock):   800-211-3573
Fax:   973-937-5557
Website:   www.merck-animal-health-usa.com
Every effort has been made to ensure the accuracy of the Nobivac Feline 3-HCP information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2020 Animalytix LLC. Updated: 2020-09-29